GastroenterologyAHB-137chronic hepatitis B
AHB-137: First-in-Human Study Shows Promising Antiviral Activity and Safety in Chronic Hepatitis B Management
By MedXY|Aug 16, 2026
AHB-137, an antisense oligonucleotide targeting HBV mRNA, demonstrated safety, favorable pharmacokinetics, and rapid HBsAg reduction in healthy volunteers and chronic hepatitis B patients, supporting further clinical development.